P26 Impact of hiatus hernia in hypersensitivity pneumonitis – experience at a tertiary centre

Autor: DA Heriot, CJW Stock, Z Mumtaz, RG Jenkins, F Chua, PL Molyneaux, A Devaraj, V Kouranos, AU Wells, EA Renzoni, SPG Padley, SR Desai, PM George

Publikováno v: ‘Scar Wars’ – The pot pourri of ILD.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f62b12bffba9b2232521a6983e5dcfe
https://doi.org/10.1136/thorax-2022-btsabstracts.162

P145 Marginal short term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis

Autor: AU Wells, Sujal R. Desai, Cjw Stock, PL Molyneaux, Felix Chua, G Margaritopoulos, C Macaluso, EA Renzoni, Peter M. George, A Devaraj, Toby M. Maher, C Boccabella, Vasilis Kouranos, Maria Kokosi, Gisli Jenkins

Publikováno v: Assessing, managing and predicting outcomes in ILD.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a72bda6c08899201e9830276fa431c8
https://doi.org/10.1136/thorax-2021-btsabstracts.254

S141 A novel dimethylarginine dimethylaminohydrolase 1 (DDAH1) genetic variant associated with lower asymmetric dimethylarginine (ADMA) levels predicts accelerated lung function decline and mortality in idiopathic pulmonary fibrosis

Autor: EA Renzoni, Harpreet K Lota, AU Wells, Cjw Stock, JM Leiper

Publikováno v: Guilt by association: ILD genetics and co-morbidities.

Background Increased nitric oxide (NO) and its generating enzyme, inducible nitric oxide synthase (iNOS), are observed in experimental models of idiopathic pulmonary fibrosis (IPF). Asymmetric dimethylarginine (ADMA) competitively inhibits iNOS and i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::614ef825ab9b7dce944500d72f0b0d0e
https://doi.org/10.1136/thorax-2018-212555.147

P32 Role of non acid and proximal reflux in scleroderma-associated interstitial lung disease

Autor: Christopher P. Denton, A Bikov, Claudia Clayman, Wim A. Wuyts, Charles Murray, Gisela E. Lindahl, Toby M. Maher, Marina Aiello, Alfredo Chetta, EA Renzoni, Voon H Ong, Simon Ward, AU Wells, Cjw Stock, Michael Kreuter, A De Lauretis, Dina Visca

Publikováno v: Thorax. 70:A92.1-A92

Background Oesophageal involvement is extremely common in patients with scleroderma. This prospective observational study (NCT02136394) addresses the relationship between gastro-oesophageal reflux (GORD) and scleroderma-associated interstitial lung d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10c374351105f1f9fcc7baf135471642
https://doi.org/10.1136/thoraxjnl-2015-207770.169

Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival.

Autor: Stock CJW; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK., Nan Y; National Heart and Lung Institute, Imperial College London, London, UK., Fang Y; National Heart and Lung Institute, Imperial College London, London, UK., Kokosi M; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK., Kouranos V; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK., George PM; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK., Chua F; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK., Jenkins GR; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK., Devaraj A; National Heart and Lung Institute, Imperial College London, London, UK.; Department of Radiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Desai SR; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Department of Radiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Denton CP; Centre for Rheumatology, Division of Medicine, UCL, London, UK., Wells AU; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK., Walsh SLF; National Heart and Lung Institute, Imperial College London, London, UK.; Department of Radiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.